Duncan Jodrell is the Professor of Cancer Therapeutics at the University of Cambridge, the Director of the Cambridge Cancer Trials Centre and the co-Lead for Experimental Cancer Medicine at the CRUK Cambridge Centre. Duncan moved to Cambridge from Edinburgh in 2008, establishing and leading an Early Phase clinical trials’ team. He has a special interest in novel therapeutic approaches for the treatment of patients with pancreatic cancer.
Key areas of interest:
CRUK Cambridge Centre research programme: Pancreatic Cancer, Cancer Immunology
Tumour type/site: Pancreatic Cancer, Early Phase Trials